Professional Documents
Culture Documents
Company
Countplus (CUP)
0.88
Services: Includes recently acquired Wealth Axis (August 2021) and Accurium (November 2021)
and reported underlying EBITA of $1.3m. Both businesses are executing on varying early stage 0.80
growth programs which likely still mask full underlying earnings potential. Based on Services 0.72
FY22a NCI’s, we estimate Wealth Axis reported a loss of $0.250m in 2H22a (Accurium $0.786m
0.63
EBITA). We expect Services costs to normalise from early 1H23e and FY23e EBITA of $2.7m.
0.55
Aug-21 Dec-21 Apr-22 Aug-22
Remediation: The remediation provision declined to $238.0m in FY22a from $273.2m in 1H22a. CUP XAO
This figure remains within the $300.0m indemnity provided by CBA. Total payments were
$35.0m at 30 June 2022, demonstrating clear progress on a yoy basis ($5.6m at 31 December 1-mth 6-mth 12-mth
2022). CUP has owned Count Financial since October 2019. Abs return (%) (2.1) (8.7) (27.5)
Rel return (%) (5.7) (8.9) (22.8)
Financial summary (Y/E Jun, AUD) FY21A FY22A FY23E FY24E FY25E Key changes 27-Jun After Var %
Sales ($m) 80.7 85.4 93.5 97.2 100.0 Sales FY23E 91.4 93.5 2%
EBITDA norm ($m) 16.1 15.7 18.3 19.5 21.9 ($m) FY24E 94.9 97.2 2%
NPAT norm ($m) 5.3 5.0 6.9 7.6 9.0 FY25E 100.0
Consensus NPAT ($m) 6.9 8.0 NPAT FY23E 6.3 6.9 10%
P/E (x) 14.3 15.3 11.1 10.1 8.5 norm FY24E 7.2 7.6 5%
Dividend yield (%) 4.0 5.1 7.2 7.9 9.3 ($m) FY25E 9.0
Price target 0.65 1.20 85%
Source: Company data, Wilsons estimate, Refinitiv.
Rating M/W O/W
All amounts are in Australian Dollar (A$) unless otherwise stated.
Catalysts Risks
Further acquisitions in the financial advice and core firms’ segments, Ongoing regulatory changes, greater penetration of robo-advice, advisers
vertical integration, more advisers joining CUP or advisers increasing leaving CUP to change careers or go to competing firms.
their book size (FUM).
P&L ($m) FY21A FY22A FY23E FY24E FY25E Balance sheet ($m) FY21A FY22A FY23E FY24E FY25E
Sales 80.7 85.4 93.5 97.2 100.0 Cash & equivalents 26.2 21.5 24.3 38.3 57.1
EBITDA norm 16.1 15.7 18.3 19.5 21.9 Current receivables 19.5 24.6 15.4 16.0 16.4
EBIT norm 10.6 9.3 12.2 13.4 16.0 Current inventory 0.0 0.0 0.0 0.0 0.0
PBT norm 9.5 8.2 11.4 12.6 15.2 PPE 4.0 3.6 4.8 4.8 4.8
NPAT norm 5.3 5.0 6.9 7.6 9.0 Intangibles 36.5 52.3 49.6 47.0 44.6
NPAT reported 4.9 4.8 6.9 7.6 9.0 Other assets 330.4 326.4 320.7 323.4 326.2
EPS norm (cents) 4.8 4.5 6.2 6.8 8.1 Total assets 416.7 428.5 414.9 429.6 449.2
DPS (cents) 2.8 3.5 4.9 5.4 6.4 Current payables 14.2 35.4 11.2 9.3 9.6
Total debt 4.3 9.8 9.8 9.8 9.8
Growth (%) FY21A FY22A FY23E FY24E FY25E Other liabilities 316.3 294.9 290.2 290.2 290.2
Sales (2.3) 5.8 9.6 3.9 2.9 Total liabilities 334.8 340.1 311.2 309.3 309.6
EBITDA norm (0.4) (2.3) 16.0 6.6 12.8 Minorities 10.7 13.1 13.1 13.1 13.1
NPAT norm (11.4) (5.2) 38.1 10.0 18.7 Shareholders equity 71.2 75.4 90.5 107.2 126.5
EPS norm (cents) (11.4) (6.2) 38.1 10.0 18.7
DPS (cents) 10.0 27.3 40.0 10.2 18.5 Cash flow ($m) FY21A FY22A FY23E FY24E FY25E
Operating cash flow 9.6 8.3 20.2 28.2 34.6
Margins and returns (%) FY21A FY22A FY23E FY24E FY25E Maintenance capex (2.0) (1.0) (5.1) (4.4) (4.4)
EBITDA margin 20.0 18.4 19.5 20.0 22.0 Free cash flow 7.6 7.3 15.1 23.9 30.2
EBIT margin 13.1 10.9 13.1 13.8 16.0 Growth capex 0.0 0.0 0.0 0.0 0.0
PBT margin 11.8 9.6 12.2 13.0 15.2 Acquisitions/disposals (1.2) (16.2) (1.7) (1.7) (1.7)
NPAT margin 6.5 5.9 7.4 7.8 9.0 Dividends paid (2.8) (3.3) (5.5) (6.1) (7.2)
ROA 2.5 2.2 2.9 3.1 3.6 Other cash flow (3.2) 1.8 (5.2) (2.2) (2.6)
ROIC 17.7 12.1 13.7 14.6 17.3 Cash flow pre-financing 0.4 (10.3) 2.8 14.0 18.8
ROE 6.4 5.7 6.7 6.3 6.5 Funded by equity 0.0 0.0 0.0 0.0 0.0
Funded by cash/debt (0.4) 4.7 (2.8) (14.0) (18.8)
Interims ($m) 2H21A 1H22A 2H22A 1H23E 2H23E
Sales 38.4 41.9 43.5 48.0 45.5 Liquidity FY21A FY22A FY23E FY24E FY25E
EBITDA norm 5.2 8.1 7.6 10.4 7.9 Cash conversion (%) 59.5 52.7 110.6 145.2 157.7
EBIT norm 2.4 5.1 4.1 7.6 4.7 Net debt ($m) (21.9) (11.7) (14.5) (28.5) (47.3)
PBT norm 1.8 4.6 3.6 7.2 4.3 Net debt / EBITDA (x) (1.4) (0.7) (0.8) (1.5) (2.2)
NPAT norm 1.2 3.5 1.5 4.3 2.6 ND / ND + Equity (%) (36.6) (15.3) (16.3) (31.0) (51.2)
NPAT reported 0.8 3.5 1.4 4.3 2.6 EBIT / Interest expense (x) 10.0 8.5 15.6 17.1 20.4
EPS norm (cents) 1.1 3.1 1.4 3.9 2.3
DPS (cents) 1.5 1.5 2.0 3.1 1.8 Valuation FY21A FY22A FY23E FY24E FY25E
EV / Sales (x) 0.7 0.8 0.7 0.5 0.3
Stock specific FY21A FY22A FY23E FY24E FY25E EV / EBITDA (x) 3.4 4.1 3.4 2.5 1.3
Core Firm rev (A$m) 64.9 64.5 65.8 67.4 69.0 EV / EBIT (x) 5.1 7.0 5.1 3.6 1.8
Financial Advice rev (A$m) 8.9 15.5 19.2 21.0 21.9 P / E (x) 14.3 15.3 11.1 10.1 8.5
Core Related rev (A$m) 0.0 5.4 8.6 8.8 9.1 P / BV (x) 0.9 0.9 0.7 0.6 0.5
EBITA (A$m) 12.0 11.4 14.0 15.1 17.6 FCF yield (%) 10.0 9.6 19.8 31.2 39.6
Dividend yield (%) 4.0 5.1 7.2 7.9 9.3
Payout ratio (%) 57.6 78.1 79.2 79.4 79.2
Franking (%) 100.0 100.0 100.0 100.0 100.0
Weighted shares (m) 110.4 111.6 111.6 111.6 111.6
• Wealth: EBITA +431.6% to $3.216m, driven by improved revenue. We are encouraged by the result,
specifically given it was the first full year result without grandfathered commissions (FY21a $1.8m).
Performance data including number of advice documents, gross business earnings and gross earnings per
adviser are all trending in the right direction and we are encouraged by the potential the latest round of
adviser inflows (+30 net in FY22a) will have on EBITA in the coming years as varying welcome rates run-
down. On an annualised basis, we estimate 30 advisers writing $0.5m/year could add $0.788k in EBITA.
• Valuation: Our valuation +84.6% to $1.20/share. Changes to our methodology include; (i) We now use
PE/DCF as this is more reflective of finance related companies and considers CUP’s affiliate ownership
position; (ii) the removal of our valuation discount which reflected strategy/key role uncertainty post
surprise departure of previous CEO in February 2022; (iii) lower beta due to CUP’s defensive qualities and;
(iv) lower TGR given greater prominence of Accounting and Advice revenue streams.
Changes to forecasts
Our NPAT forecasts +10.3% (vs. prev.) to $6.9m in FY23e, reflective of changes outlined below:
o Accounting revenue: +3.3% (vs. prev.) to $65.8m driven by the better than expected revenue
growth in this segment (+3.4% vs. WILSe in FY22a). Our forecasts reflect +2.5% yoy growth for
Accounting firms in FY23e.
o Wealth revenue: Largely unchanged (vs. prev.) in FY23e. However, our forecasts +5.1% (vs.
prev.) to FY24e as we estimate growth in the CUP’s share of GBE (+100bps yoy to 6.5%) as
adviser discounts roll off. We assume adviser growth of 12 per year in the Wealth vertical.
o Services revenue: Largely unchanged (vs. prev.) in FY23e. However, our forecasts -9.3% (vs.
prev.) to $8.8m in FY24e as we lower expectations for the education platform revenue within
Accurium (Actuarial certificate business).
• Associate income: +10.1% (vs. prev.) to $4.4m, Now reflective of the WSC Group acquisition (32.75%
stake), effective 1 August 2022. We estimate CUP’s share of EBITA in WSC is $0.4m.
Source: WILSe.
Key charts
Figure 2: Revenue by vertical (A$m) Figure 3: Net cash and NPAT forecasts (A$m)
120.0 30.0 28.5
93.5 97.2
100.0
85.4 8.8 25.0
76.3 8.6 21.1 21.9
80.0 73.8 5.4
19.2 21.0
12.5 8.9 15.5 20.0
A$m
60.0
14.5
15.0
40.0 11.7
63.8 64.9 64.5 65.8 67.4
10.0 7.6
20.0 6.9
6.0 5.3 5.0
0.0 5.0
FY20a FY21a FY22a FY23e FY24e
0.0
FY20a FY21a FY22a FY23e FY24e
Accounting revenue Wealth revenue Services revenue
Net cash NPAT
Source: CUP Company data, WILSe. Source: CUP Company data, WILSe.
Figure 2: EBITA forecasts (A$m) Figure 3: CUP multiples vs. Kelly Partners
16.0 18.0% 35.0
14.0 16.0% 29.7
30.0
12.0 14.0%
EBITA margin (%)
12.0% 25.0
EBITA (A$m)
10.0
10.0%
Multiple
8.0 20.0
8.0%
6.0 15.0
6.0%
4.0 10.6 10.7
4.0%
10.0
2.0 2.0% 5.1
0.0 0.0% 5.0
FY20a FY21a FY22a FY23e FY24e
0.0
EBITA EBITA margin FY23e EV/EBITDA FY23e P/E
12.0 11.4
10.3
15.0% 10.0 9.3
A$m
7.7 7.4
8.0 7.2
10.0%
6.0
5.0% 4.0
2.0
0.0%
Accounting Wealth Services 0.0
FY20a FY21a FY22a FY23e FY24e
FY21a FY22a EBITA Underlying NPAT
Source: CUP Company data, WILSe. Source: CUP Company data, WILSe.
Definitions at wilsonsadvisory.com.au/disclosures.
| Analyst certification
Each analyst of Wilsons Advisory and Stockbroking Limited (ACN 010 529 665: AFSL 238375) (“Wilsons”) whose name appears in this research
certifies that (1) the recommendations and opinions expressed in this research accurately reflect the analyst’s personal, independent and objective views
about any and all of the subject securities or issuers; (2) no part of the analyst’s compensation was, is, or will be, directly or indirectly, related to the
specific recommendations or views expressed by the analyst in the research; and (3) to the best of the analyst’s knowledge, he/she is not in receipt of
material non-public information about the issuer.
| Disclaimer
This document has been prepared by Wilsons. This communication is not to be disclosed in whole or part or used by any other p arty without Wilsons’
prior written consent. All material presented in this document, unless specifically indicated otherwise, is under copyright to Wilsons. None of the
material, its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express
written permission of Wilsons. This document is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident
of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or
regulation or which would subject Wilsons to any registration or licensing requirement within such jurisdiction.
This document is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this document. To the
extent that any information prepared by Wilsons contains any financial product advice, it is general advice only and has been prepared by Wilsons
without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives,
financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document
before making any decision to acquire a financial product. Please refer to Wilsons’ Financial Services Guide for more information:
wilsonsadvisory.com.au/disclosures. Any person, before acting on any advice contained within this communication, should first consult with a Wilsons
investment adviser to assess whether the advice within this communication is appropriate for their objectives, financial situation and needs. Those acting
upon such information without advice do so entirely at their own risk.
This document provided by Wilsons is current as at the date of the issue but may be superseded by future publications. Wilsons assumes no obligation
to update the information or advise on further developments relating to the company or companies covered in this document (“Companies”) or relevant
financial products. Wilsons has not independently verified all of the information given in this document which is provided at a point in time and may not
contain all necessary information about the Companies. Wilsons makes no warranty, express or implied, concerning any information prepared by
Wilsons. Wilsons expressly disclaims (1) any implied warranty of merchantability or (2) fitness for a particular purpose, including any warranty for the
use or the results of the use of any information prepared by Wilson s with respect to their correctness, quality, accuracy, completeness, reliability,
performance, timeliness, or continued availability. Wilsons’ research content should be viewed as an additional investment resource, not as your sole
source of information. To the fullest extent permitted by law Wilsons, its related bodies corporate and their respective officers, directors, employees or
agents, disclaim any and all liabilities for any loss or damage howsoever arising in connection with the use of this document or its contents. Past
performance does not necessarily indicate a financial product’s likely future performance.
This document may contain “forward-looking statements”. Forward-looking statements, opinions and estimates provided in this document are based on
assumptions and contingencies which are outside the control of Wilsons and are subject to change without notice (including but not limited to economic
conditions, market volatility and company-specific fundamentals), and therefore may not be realised in the future.
This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or
commitment whatsoever.
Wilsons restricts research analysts from trading in securities for which they write research. Other Wilsons employees may hold interests in the company,
but none of those interests are material. Wilsons further advises that at the date of this report, neither Wilsons Advisory and Stockbroking Limited or
Wilsons Corporate Finance Limited have any material interests in the company. Wilsons Corporate Finance Limited ACN 057 547 323, AFSL 238 383
has been appointed as broker for the CountPlus Limited Securities on-market buyback, announced June 2022, for which it received fees or will receive
fees for acting in this capacity.
Wilsons Advisory and Stockbroking Limited may have a conflict of interest which investors should consider before making an investment decision.
Wilsons Advisory and Stockbroking Limited, Wilsons Corporate Finance Limited and its related bodies corporate trades or may trade as principal in the
securities that are subject of the research report. Wilsons further advises that at the date of this report, neither Wilsons Advisory and Stockbroking
Limited or Wilsons Corporate Finance Limited have any material interests in the company. Wilsons restricts research analysts from trading in securities
for which they write research. Other Wilsons employees may hold interests in the company, but none of those interests are material.
| Wilsons contact
For more information please phone: 1300 655 015 or email: publications@wilsonsadvisory.com.au